Quest Diagnostics Incorporated
241.89USD
-1.3900 (-0.57%)
Fetching financial statements from SEC filings…
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on DGX.
| In $M except per-share | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3,097 | 3,043 | 2,895 | 2,806 | 2,816 | 2,761 | 2,652 | 2,621 |
| Cost of Revenue | 2,055 | 2,016 | 1,953 | 1,896 | 1,867 | 1,818 | 1,789 | 1,763 |
| Gross Profit | 1,042 | 1,027 | 942 | 910 | 949 | 943 | 863 | 858 |
| Operating Income | 479 | 459 | 399 | 386 | 386 | 438 | 346 | 361 |
| Net Income | 312 | 320 | 252 | 245 | 245 | 282 | 220 | 222 |
| EPS (Diluted) | $2.78 | $2.84 | $2.24 | $2.18 | $2.16 | $2.47 | $1.94 | $1.95 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)